ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Geriatric Medicine

Top Geriatric Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KHOREN HEKIMIAN DO

Geriatric Medicine

67,122

$4.67M

1287
946 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $64

CHARLES MAXVILL DO

Geriatric Medicine

56,911

$3.64M

1085
900 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $64

JIBRAIL KASPERKHAN M.D.

Geriatric Medicine

44,085

$3.03M

760
682 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

REZIUDDIN SIDDIQUE M. D.

Geriatric Medicine

43,748

$2.66M

1039
860 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

RADU CIUBUC MD

Geriatric Medicine

33,861

$2.47M

845
749 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $64

OMAR ZANTUA M.D.

Geriatric Medicine

25,352

$2M

469
419 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $64

KENT DAVIS MD

Geriatric Medicine

33,573

$1.93M

895
777 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

32%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $64

NEETA NAYAK MD

Geriatric Medicine

29,948

$1.75M

739
611 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $64

FOLASADE OJO MD

Geriatric Medicine

26,715

$1.73M

514
416 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $64

ALEJANDRO ARIZMENDI MD

Geriatric Medicine

22,010

$1.61M

1628
1277 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $64

PEDRO MCDOUGAL M.D. F.A.C.P.

Geriatric Medicine

20,524

$1.57M

1634
1324 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $64

MELCHOR ACOSTA MD

Geriatric Medicine

24,697

$1.41M

522
459 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $64

SOROUSH BEHNAM MD

Geriatric Medicine

24,918

$1.39M

733
686 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $64

ANTHONY NGUYEN D.O.

Geriatric Medicine

12,108

$1.37M

730
673 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $64

BIJU OOMMEN M.D.

Geriatric Medicine

23,664

$1.34M

681
599 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $64

EMMANUEL EDOKA M.D

Geriatric Medicine

15,139

$1.22M

373
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $64

JILL STUDLEY

Geriatric Medicine

19,224

$1.2M

1067
1037 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $64

JOYCE THOMPSON M.D.

Geriatric Medicine

20,868

$1.18M

718
698 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $64

SHIVA SATISH M.D.

Geriatric Medicine

20,553

$1.17M

670
633 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $64

ARUSHA BAVARE M.D.

Geriatric Medicine

17,829

$1.07M

686
635 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

ANIL GARYALI M.D.

Geriatric Medicine

17,509

$1.05M

272
236 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

FRANCISCO RUGAMA MD

Geriatric Medicine

11,595

$1.02M

444
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$88
Average prescription price

Avg: $64

SUE CROW MD

Geriatric Medicine

14,646

$1.01M

801
697 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

ILSONG CHONG M.D.

Geriatric Medicine

15,757

$938K

448
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

MILTON SHEPPERD DO

Geriatric Medicine

14,386

$844K

369
345 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank